Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Form 8.3 APAX GLOBAL ALPHA LTD

12 Sep 2025 14:38

RNS Number : 1970Z
Barclays PLC
12 September 2025
ย 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

ย 

Barclays PLC.

(b)

Owner or controller of interest and short

ย 

ย 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

APAX GLOBAL ALPHA LTD

ย 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

ย 

ย 

offeror/offeree, state this and specify identity of

ย 

offeror/offeree:

(e)

Date position held/dealing undertaken:

11 Sep 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

ย 

ย 

ย 

disclosures in respect of any other party to the offer?

ย 

ย 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

ย 

ย 

to which the disclosure relates following the dealing(if any)

ย 

Class of relevant security:

Ordinary NPV

ย 

Interests

Short Positions

ย 

Number

(%)

Number

(%)

(1)

Relevant securities owned

ย 

ย 

ย 

ย 

ย 

and/or controlled:

ย 

ย 

6,474,229

1.34%

143,878

0.03%

(2)

Cash-settled derivatives:

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

33,280

0.01%

6,469,686

1.34%

(3)

Stock-settled derivatives (including options)

ย 

ย 

ย 

ย 

ย 

and agreements to purchase/sell:

ย 

ย 

0

0.00%

0

0.00%

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

TOTAL:

ย 

ย 

6,507,509

1.35%

6,613,564

1.37%

(b)

Rights to subscribe for new securities (including directors and other executive

ย 

ย 

options)

ย 

ย 

ย 

ย 

ย 

ย 

Class of relevant security in relation to

ย 

ย 

ย 

ย 

which subscription right exists

ย 

ย 

ย 

ย 

Details, including nature of the rights

ย 

ย 

ย 

ย 

concerned and relevant percentages:

ย 

ย 

ย 

ย 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

ย 

ย 

ย 

ย 

ย 

Class of relevant

Purchase/sale

Number of

Price per unit

security

ย 

securities

ย 

Ordinary NPV

Purchase

1,000,000

1.6443 GBP

Ordinary NPV

Purchase

2,332

1.6360 GBP

Ordinary NPV

Sale

415,585

1.6380 GBP

Ordinary NPV

Sale

23,876

1.6361 GBP

Ordinary NPV

Sale

16,778

1.6359 GBP

Ordinary NPV

Sale

5,472

1.6360 GBP

Ordinary NPV

Sale

3,068

1.6420 GBP

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(b)

Cash-settled derivative transactions

ย 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

ย 

reference

unit

security

ย 

ย 

securities

ย 

Ordinary NPV

SWAP

Decreasing Short

16,778

1.6359 GBP

Ordinary NPV

SWAP

Decreasing Short

15,737

1.6360 GBP

Ordinary NPV

SWAP

Decreasing Short

415,585

1.6380 GBP

Ordinary NPV

SWAP

Decreasing Short

3,608

1.6420 GBP

Ordinary NPV

SWAP

Increasing Short

1,000,000

1.6443 GBP

Ordinary NPV

CFD

Decreasing Short

12,868

1.6364 GBP

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(c)

Stock-settled derivative transactions (including options)

ย 

(i)

Writing, selling, purchasing or varying

ย 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

ย 

date

money

relevant

ย 

selling,

securities

per unit

ย 

ย 

paid/

security

ย 

varying etc

to which

ย 

ย 

ย 

received

ย 

ย 

ย 

option

ย 

ย 

ย 

per unit

ย 

ย 

ย 

relates

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(ii)

Exercise

ย 

ย 

ย 

ย 

ย 

ย 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

ย 

ย 

securities

unit

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

(d)

Other dealings (including subscribing for new securities)

ย 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

ย 

ย 

applicable)

ย 

ย 

ย 

ย 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

ย 

Details of any indemnity or option arrangement, or any agreement or understanding,

ย 

ย 

formal or informal, relating to relevant securities which may be an inducement to deal

ย 

ย 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

ย 

to the offer or any person acting in concert with a party to the offer:

ย 

ย 

ย 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

ย 

Details of any agreement, arrangement or understanding, formal or informal, between

ย 

ย 

the person making the disclosure and any other person relating to:

ย 

ย 

(i) the voting rights of any relevant securities under any option; or

ย 

ย 

ย 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

ย 

ย 

any derivative is referenced:

ย 

ย 

ย 

ย 

ย 

ย 

NONE

(c)

Attachments

ย 

ย 

ย 

ย 

ย 

ย 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

12 Sep 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
RETPKBBBNBKDFCD
Date   Source Headline
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSDirector Appointment
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSApax Funds support WGSN in the acquisition of IWSR
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSApax Funds to acquire Finastra’s TCM Division
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSApax Funds to take Norva24 private
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.